BiotechTube
Home/IHP Therapeutics/Kate Stuart
KS

Kate Stuart

VP of Program Management

IHP Therapeutics

Therapeutic Areas

HematologyOncology

IHP Therapeutics Pipeline

DrugIndicationPhase
IHP-102Acute vaso-occlusive crisis in sickle cell diseasePre-clinical

Leadership Team at IHP Therapeutics

RG
Rinko Ghosh
President and CEO
JP
John Paderi
Chief Scientific Officer
GN
Gabriel Njikang
CMC
View full IHP Therapeutics profile